(Q36221957)

12 August 2017

1 reference

title

Personalised medicine for cancer: from drug development into clinical practice (English)

1 reference

12 August 2017

Jain KK

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Expert Opinion on Pharmacotherapy

12 August 2017

published in

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

9

1 reference

12 August 2017

page(s)

1463-1476

1 reference

Gene expression microarray technologies in the development of new therapeutic agents

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

The relevance of alternative RNA splicing to pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Splice variants as cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Modification of alternative splicing by antisense therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Accurate detection of aneuploidies in array CGH and gene expression microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Applications of eTag trade mark assay platform to systems biology approaches in molecular oncology and toxicology studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Clinical implications of advanced molecular cytogenetics in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Molecular diagnosis of the hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Human aspartyl (asparaginyl) beta-hydroxylase monoclonal antibodies: potential biomarkers for pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Development of the proteasome inhibitor Velcade (Bortezomib).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Genes expressed in human tumor endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

New anti-cancer strategies: epigenetic therapies and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

DNA methylation and cancer therapy: new developments and expectations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Role of oncoproteomics in the personalized management of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Identifying good diagnostic gene groups from gene expression profiles using the concept of emerging patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Genome-wide discovery of loci influencing chemotherapy cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Pharmacogenetics in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Cancer therapy and polymorphisms of cytochromes P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Drug methylation in cancer therapy: lessons from the TPMT polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Determination of tumour marker genes from gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

DNA microarrays in clinical cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

Immunotargeted nanoshells for integrated cancer imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.9.1463

10.1517/14656566.6.9.1463

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference